Zenas BioPharma
Post-IPO DebtMar 2026

Post-IPO Debt — Zenas BioPharma

$200.0MRaised

Overview

Organization

Zenas BioPharma

Funding Type

Post-IPO Debt

Additional funding details

Free accounts get 25 credits every month. A funding reveal uses credits.

About Zenas BioPharma

Biotech
Healthcare
Life Sciences

Boston, United States

View Full Profile